Halle, O., Graeber, S. Y., Kontsendorn, J., Kessemeier, C., Falke, J., Schwabe, J., . . . Dittrich, A. (2025). Reduction of systemic inflammation by elexacaftor/tezacaftor/ivacaftor correlates with lung function improvement in cystic fibrosis. The European respiratory journal, 66(6), . https://doi.org/10.1183/13993003.00150-2025
Chicago-Zitierstil (17. Ausg.)Halle, Olga, et al. "Reduction of Systemic Inflammation by Elexacaftor/tezacaftor/ivacaftor Correlates with Lung Function Improvement in Cystic Fibrosis." The European Respiratory Journal 66, no. 6 (2025). https://doi.org/10.1183/13993003.00150-2025.
MLA-Zitierstil (9. Ausg.)Halle, Olga, et al. "Reduction of Systemic Inflammation by Elexacaftor/tezacaftor/ivacaftor Correlates with Lung Function Improvement in Cystic Fibrosis." The European Respiratory Journal, vol. 66, no. 6, 2025, https://doi.org/10.1183/13993003.00150-2025.